Lepu Biopharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Mar '26 Mar 9, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	8,030	4,482	6,986	12,197	-	-	Upgrade
Market Cap Growth	50.93%	-35.85%	-42.72%	-	-	-	Upgrade
Enterprise Value	8,410	4,671	7,196	11,782	-	-	Upgrade
Last Close Price	4.45	2.62	4.21	7.35	-	-	Upgrade
PS Ratio	10.46	11.45	28.14	692.84	-	-	Upgrade
PB Ratio	10.29	6.18	7.14	11.98	-	-	Upgrade
P/TBV Ratio	20.69	15.74	13.71	23.98	-	-	Upgrade
EV/Sales Ratio	10.96	11.93	28.99	669.30	-	-	Upgrade
Debt / Equity Ratio	1.29	1.25	0.84	0.77	0.40	0.14	Upgrade
Net Debt / Equity Ratio	0.53	0.55	0.28	0.01	0.14	-0.37	Upgrade
Net Debt / EBITDA Ratio	-6.05	-1.19	-0.81	-0.02	-0.14	1.46	Upgrade
Net Debt / FCF Ratio	-4.35	-1.63	-0.89	-0.02	-0.14	0.84	Upgrade
Asset Turnover	0.29	0.16	0.09	0.01	-	-	Upgrade
Inventory Turnover	2.35	2.87	1.06	0.08	-	-	Upgrade
Quick Ratio	0.56	0.54	0.62	0.83	0.39	1.99	Upgrade
Current Ratio	0.63	0.62	0.75	0.96	0.57	2.21	Upgrade
Return on Equity (ROE)	-24.53%	-54.02%	-3.39%	-80.03%	-87.61%	-93.22%	Upgrade
Return on Assets (ROA)	-3.94%	-10.61%	-9.94%	-17.41%	-26.18%	-14.16%	Upgrade
Return on Capital Employed (ROCE)	-12.10%	-32.00%	-26.30%	-38.10%	-61.60%	-21.90%	Upgrade
Earnings Yield	-2.42%	-9.77%	-0.35%	-6.39%	-	-	Upgrade
FCF Yield	-1.19%	-5.45%	-4.40%	-5.48%	-	-	Upgrade
Buyback Yield / Dilution	-2.76%	-1.87%	-1.14%	-7.92%	-33.97%	-74.89%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.